Translational medicine in oncology
3 European H2020 organizations list this as part of their work.
Most active in this area
- STIFTUNG ELN FOUNDATION
German foundation powering Europe's hematology research network with big data platforms for blood cancer patient outcomes.
“HARMONY PLUS explicitly lists translational medicine and molecular genetics as focus areas, signaling a shift toward bench-to-bedside research.”
DE3 projects - GPOH GEMEINNUTZIGE GMBH
German non-profit society linking pediatric oncology clinical centers to European big data research on blood cancers and hematological malignancies.
“HARMONY PLUS introduced translational medicine and molecular genetics keywords, indicating a move toward integrating genomic data with clinical outcomes.”
DE2 projects - EUROPEAN RESEARCH INITIATIVE ON CLL EV
German hematology research association specializing in leukemia, lymphoma, and blood cancer real-world patient data within Europe's HARMONY platform.
“HARMONY PLUS (2020-2024) introduced translational medicine and molecular genetics keywords, reflecting a move from data aggregation toward clinical application.”
DE2 projects